Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Agranulocytosis associated with etodolac

R L Cramer1, V C Aboko-Cole, R J Gualtieri

  • 1Department of Pharmacy, Huntsville Hospital, AL 35801.

The Annals of Pharmacotherapy
|April 1, 1994
PubMed
Summary

This case report details a probable instance of etodolac-induced agranulocytosis, a rare side effect of nonsteroidal anti-inflammatory drugs (NSAIDs). Clinicians should monitor for this serious adverse event associated with etodolac use.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activated protein C resistance and Sneddon's syndrome.

The American journal of medicine·1999
Same author

Antithymocyte globulin-induced adult respiratory distress syndrome.

Archives of internal medicine·1998
Same author

Malignant supratentorial glial-neuronal neoplasms: report of two cases and review of the literature.

Archives of pathology & laboratory medicine·1997
Same author

Reactions to fosphenytoin editorial and review article.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1997
Same author

A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia.

The New England journal of medicine·1994
Same author

Drug interaction monitoring program in a community hospital.

American journal of hospital pharmacy·1992

Area of Science:

  • Pharmacology
  • Hematology
  • Clinical Medicine

Background:

  • Agranulocytosis is a rare but serious adverse effect associated with some nonsteroidal anti-inflammatory drugs (NSAIDs).
  • Literature reports linking etodolac to agranulocytosis are notably absent.